A single-centre study of 109 cancer patients undergoing treatment with anthracyclines showed that 10.1% of patients experienced a cardiac event (namely LV dysfunction, symptomatic HF, arrhythmia, sudden cardiac death or ACS), and all of these patients had a BNP > 100 ng/L prior to the event [92]. This evidence concerns the gene NPPB and hydrops fetalis.